Rosemary Ffrench

2.1k citations
43 papers · 1.5k indexed · h-index 20

Rosemary Ffrench

42 papers receiving 1.4k citations

Peers

Rosemary Ffrench
Comparison fields: 5 of 89
  • Hepatology 687
  • Virology 300
  • Immunology 488
  • Gastroenterology 122
  • Epidemiology 748
Replace Susan McKiernan with:
Susan McKiernan Ireland
Thomas Kuntzen United States
Stewart Cooper United States
Daniel A. Donahue Canada
G. L. Toms United Kingdom
Sylvie Lagaye France
Deborah Marcus-Bagley United States
Manfred Wiese Germany
Harvey J. Alter United States
Huiping Yan China
Rosemary Ffrench relative to Susan McKiernan Ireland Susan McKiernan's profile →
Citations per field
00.5×3.4×
Susan McKiernan · 1×
Citations per year

Countries citing papers authored by Rosemary Ffrench

Since Specialization
Citations

This map shows the geographic impact of Rosemary Ffrench's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Ffrench with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Ffrench more than expected).

Fields of papers citing papers by Rosemary Ffrench

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Ffrench. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Ffrench. The network helps show where Rosemary Ffrench may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rosemary Ffrench, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rosemary Ffrench Line = papers co-authored together Rosemary Ffrench links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20203
2 201923
3 20184
4 201317
5 201219
6 201051
7 201049
8 20100
9 200814
10 200526
11 200512
12 200444
13 20042
14 200316
15 200357
16 200317
17 20017
18 20018
19
Immunogenicity of an HIV polytope vaccine containing multiple HLA-A2 HIV CD8+ cytotoxic T cell epitopes
19991
20 19988

About Rosemary Ffrench

Rosemary Ffrench is a scholar working on Hepatology, Virology and Immunology, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (13 papers), Immune Cell Function and Interaction (11 papers), HIV Research and Treatment (10 papers), vaccines and immunoinformatics approaches (6 papers), Systemic Lupus Erythematosus Research (6 papers), Influenza Virus Research Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (687 citations), Virology (300 citations) and Immunology (488 citations). Rosemary Ffrench has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew R. Lloyd, George Marinos, Anthony Freeman, Jeffrey J. Post, William D. Rawlinson, Charles Harvey, Patricia Palladinetti, Peter A. White, Rakesh Kumar and John Kaldor. Their work appears in journals such as Journal of Virology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026